Zhaoke Ophthalmic (兆科眼科) Pre-IPO: Thoughts on Valuation
In this note, we provide a forecast on Zhaoke Ophthalmic's two core products CsA ophthalmic gel and the ZKY001 and an SOTP based valuation for the...
381 Views
ECM Weekly (5th April 2021) - Nayuki, Peter Warren, Linklogis, Zhaoke Ophthalmic, Macrotech Dev
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
334 Views
Zhaoke Ophthalmic (兆科眼科): Could Be Over-Valued for Pre-IPO Round
The company has an OK management team but strong backing of institutional investors. We think the pre-IPO valuation could be too high.
372 Views
Pre-IPO Zhaoke Ophthalmology Pharmaceutical - It Remains to Be Seen How to Find Its Way Out
The article analyzed Zhaoke Ophthalmology in terms of pipeline, competitive landscape, financial position and also included concerns for the future...
532 Views
Zhaoke Ophthalmology: Bringing Focus to China
Zhaoke Ophthalmology is a pre-revenue pharmaceutical company specializing in ophthalmic drugs for China that has filed to list on the HKEX. Lee's...
423 Views